Alkeon Capital Management
KLRS

Alkeon Capital Management’s Kalaris Therapeutics KLRS Stock Holding History

Alkeon Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200,222
Closed -$9.9M – 117
2023
Q3 		$9.9M Hold
200,222
– – 0.06% 93
2023
Q2 		$15.7M Hold
200,222
– – 0.09% 100
2023
Q1 		$18.1M Hold
200,222
– – 0.12% 101
2022
Q4 		$23.6M Sell
200,222
-13,826
-6% -$2.35M 0.18% 102
2022
Q3 		$38.8M Buy
214,048
+94,313
+79% +$14.7M 0.27% 100
2022
Q2 		$10.7M Buy
119,735
+86,956
+265% +$9.12M 0.06% 123
2022
Q1 		$5.09M Sell
32,779
-526
-2% -$105K 0.02% 139
2021
Q4 		$9.91M Sell
33,305
-14,239
-30% -$6.61M 0.03% 139
2021
Q3 		$27.4M Hold
47,544
– – 0.09% 128
2021
Q2 		$21.6M Sell
47,544
-152
-0.3% -$78.5K 0.08% 140
2021
Q1 		$25.7M Hold
47,696
– – 0.1% 129
2020
Q4 		$42.2M Hold
47,696
– – 0.16% 119
2020
Q3 		$30.2M Buy
+47,696
New +$32.6M 0.14% 113

Other funds holding KLRS

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return